Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2015, Article ID 920409, 8 pages
http://dx.doi.org/10.1155/2015/920409
Research Article

Intratumoral CD3+ T-Lymphocytes Immunoexpression and Its Association with c-Kit, Angiogenesis, and Overall Survival in Malignant Canine Mammary Tumors

1CECAV, University of Trás-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal
2Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal
3School of Life Sciences and the Environment, University of Trás-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal
4Centro Hospitalar Veterinário, Rua Manuel Pinto de Azevedo 118, 4100-320 Porto, Portugal
5Hospital Veterinário do Porto, Travessa Silva Porto 174, 4250-475 Porto, Portugal
6Faculdade de Medicina Veterinária, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisboa, Portugal
7Center for the Study of Animal Sciences, CECA-ICETA, University of Porto, 4051-401 Porto, Portugal
8Center for Research and Technology of Agro-Environment and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal

Received 28 April 2015; Accepted 9 July 2015

Academic Editor: Giovanni Tuccari

Copyright © 2015 Maria Isabel Carvalho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ben-Baruch, “Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions,” Breast Cancer Research, vol. 5, no. 1, pp. 31–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. I. Carvalho, I. Pires, J. Prada, and F. L. Queiroga, “A role for T-lymphocytes in human breast cancer and in canine mammary tumors,” BioMed Research International, vol. 2014, Article ID 130894, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Mantovani, F. Marchesi, C. Porta, A. Sica, and P. Allavena, “Inflammation and cancer: breast cancer as a prototype,” Breast, vol. 16, no. 2, pp. 27–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. G. DeNardo and L. M. Coussens, “Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression,” Breast Cancer Research, vol. 9, no. 4, article 212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. G. DeNardo, P. Andreu, and L. M. Coussens, “Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity,” Cancer and Metastasis Reviews, vol. 29, no. 2, pp. 309–316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani, “Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability,” Carcinogenesis, vol. 30, no. 7, pp. 1073–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Lu, W. Ouyang, and C. Huang, “Inflammation, a key event in cancer development,” Molecular Cancer Research, vol. 4, no. 4, pp. 221–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. N. Georgiannos, A. Renaut, A. W. Goode, and M. Sheaff, “The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators,” Surgery, vol. 134, no. 5, pp. 827–834, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Carlomagno, F. Perrone, R. Lauria et al., “Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer,” Oncology, vol. 52, no. 4, pp. 272–277, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. M. I. Carvalho, I. Pires, J. Prada, and F. L. Queiroga, “T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications,” In Vivo, vol. 25, no. 6, pp. 963–969, 2011. View at Google Scholar · View at Scopus
  11. A. Estrela-Lima, M. S. S. Araújo, J. M. Costa-Neto et al., “Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates,” BMC Cancer, vol. 10, article 256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Saeki, Y. Endo, K. Uchida, R. Nishimura, N. Sasaki, and T. Nakagawa, “Significance of tumor-infiltrating immune cells in spontaneous canine mammary gland tumor: 140 cases,” The Journal of Veterinary Medical Science, vol. 74, no. 2, pp. 227–230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. H. Macchetti, H. R. C. Marana, J. S. Silva, J. M. de Andrade, A. Ribeiro-Silva, and S. Bighetti, “Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement,” Clinics, vol. 61, no. 3, pp. 203–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. B.-C. Sheu, W.-H. Kuo, R.-J. Chen, S.-C. Huang, K.-J. Chang, and S.-N. Chow, “Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer,” Breast, vol. 17, no. 6, pp. 604–610, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Ray, N. Krishnamoorthy, T. B. Oriss, and A. Ray, “Signaling of c-kit in dendritic cells influences adaptive immunity,” Annals of the New York Academy of Sciences, vol. 1183, pp. 104–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Huang, Z. Lei, G.-M. Zhang et al., “SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment,” Blood, vol. 112, no. 4, pp. 1269–1279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. T. B. Oriss, N. Krishnamoorthy, P. Ray, and A. Ray, “Dendritic cell c-kit signaling and adaptive immunity: implications for the upper airways,” Current Opinion in Allergy and Clinical Immunology, vol. 14, no. 1, pp. 7–12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Liang, Y.-L. Wu, B.-J. Chen, W. Zhang, Y. Tanaka, and H. Sugiyama, “The C-kit receptor-mediated signal transduction and tumor-related diseases,” International Journal of Biological Sciences, vol. 9, no. 5, pp. 435–443, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Chui, H. Egami, J. Yamashita et al., “Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues,” British Journal of Cancer, vol. 73, no. 10, pp. 1233–1236, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. C. D. Ko, J. S. Kim, B. G. Ko et al., “The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium,” Clinical & Experimental Metastasis, vol. 20, no. 7, pp. 593–597, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. E. Roussidis, A. D. Theocharis, G. N. Tzanakakis, and N. K. Karamanos, “The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer,” Current Medicinal Chemistry, vol. 14, no. 7, pp. 735–743, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Tsuda, D. Morita, M. Kimura et al., “Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation,” Cancer Science, vol. 96, no. 1, pp. 48–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. M. Amin, A. K. El-Hawary, and O. Farouk, “Relation of CD117 immunoreactivity and microvascular density in invasive breast carcinoma,” Indian Journal of Pathology & Microbiology, vol. 55, no. 4, pp. 456–460, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Tsutsui, K. Yasuda, K. Suzuki et al., “A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer,” British Journal of Cancer, vol. 94, no. 12, pp. 1874–1878, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Brunetti, G. Beha, C. Benazzi, V. Bondin, L. De Tolla, and G. Sarli, “CD117 expression influences proliferation but not survival in canine mammary tumours,” Journal of Comparative Pathology, vol. 151, no. 2-3, pp. 202–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Kubo, S. Matsuyama, K. Katayama et al., “Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor,” The Journal of Veterinary Medical Science, vol. 60, no. 12, pp. 1335–1340, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Morini, G. Bettini, R. Preziosi, and L. Mandrioli, “C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections,” Journal of Histochemistry & Cytochemistry, vol. 52, no. 5, pp. 705–708, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Misdorp, Histological Classification of Mammary Tumors of the Dog and the Cat, Armed Forces Institute of Pathology in Cooperation with the American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington, DC, USA, 1999.
  29. M. H. Goldschmidt, L. Peña, R. Rasotto, and V. Zappulli, “Classification and grading of canine mammary tumors,” Veterinary Pathology, vol. 48, no. 1, pp. 117–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. F. L. Queiroga, I. Pires, M. Parente, H. Gregório, and C. S. Lopes, “COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer,” Veterinary Journal, vol. 189, no. 1, pp. 77–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. I. Carvalho, M. J. Guimarães, I. Pires et al., “EGFR and microvessel density in canine malignant mammary tumours,” Research in Veterinary Science, vol. 95, no. 3, pp. 1094–1099, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. T. P. Raposo, I. Pires, M. I. Carvalho, J. Prada, D. J. Argyle, and F. L. Queiroga, “Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours,” Veterinary and Comparative Oncology, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Gomes, F. L. Queiroga, J. Prada, and I. Pires, “Study of c-kit immunoexpression in canine cutaneous melanocytic tumors,” Melanoma Research, vol. 22, no. 3, pp. 195–201, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Ben-Baruch, “Breast cancer progression: a ‘Vicious Cycle’ of pro-malignancy activities is mediated by inflammatory cells, chemokines and cytokines,” in Integration/Interaction of Oncologic Growth, vol. 15 of Cancer Growth and Progression, pp. 189–217, Springer Netherlands, 2005. View at Publisher · View at Google Scholar
  35. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Hanahan and J. Folkman, “Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis,” Cell, vol. 86, no. 3, pp. 353–364, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Lemmon and J. Schlessinger, “Cell signaling by receptor tyrosine kinases,” Cell, vol. 141, no. 7, pp. 1117–1134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. R. D. Leek, “The prognostic role of angiogenesis in breast cancer,” Anticancer Research, vol. 21, no. 6, pp. 4325–4331, 2001. View at Google Scholar · View at Scopus
  39. J. L. Yu and J. W. Rak, “Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis,” Breast Cancer Research, vol. 5, no. 2, pp. 83–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Litz and G. W. Krystal, “Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells,” Molecular Cancer Therapeutics, vol. 5, no. 6, pp. 1415–1422, 2006. View at Publisher · View at Google Scholar · View at Scopus